Patient support programs play a crucial role in helping individuals manage their conditions and adhere to treatment regimens. Despite investing over $5.7 billion (about $18 per person in the US) by the pharmaceutical industry in patient support programs, the utilization of these programs remains lower than 5%. To better understand the dynamics at play, Phreesia conducted a comprehensive survey to assess patient awareness, usage, and perceptions of support programs. The survey included 4,869 participants, with a majority under 65 years old (69%) and female (65%). Notably, 69% of respondents were on medication, reflecting a relevant sample for evaluating patient support programs. Key findings include: · Patient Needs: 79% of patients who value support programs found specific ones helpful. · Low Usage and Familiarity: Only 8% of patients reported having used such programs, and a mere 3% were currently using them. This low utilization can be attributed to a significant lack of familiarity: 59% of patients had little to no knowledge of these programs. · Usage Patterns: Patients typically engage with these resources during key moments in their treatment journey, such as starting a new medication, receiving a first diagnosis, or switching medications. However, 61% of patients do not perceive much value in these programs, suggesting that existing support services may not fully meet patient needs or expectations. · Desired Support Services: Patients expressed a desire for more support, particularly in areas such as medication adherence, emotional support, and educational resources. · Awareness Channels: There is a significant opportunity to expand and optimize the channels through which patients learn about support programs. While 44% of patients learned about support programs online, a majority (55%) still preferred to receive this information from their doctors. The lack of awareness and underutilization of patient support programs highlights the urgent need for improved efforts from healthcare providers and pharmaceutical companies. Tailored marketing campaigns, integrated omnichannel plans, and enhanced online experiences can significantly increase awareness and access to these programs. Also, partnering with pharmacies for educational outreach and expanding support services for continuous patient assistance can enhance these initiatives' effectiveness. #Pharmaceuticals #Healthcare #PatientCentricity #PatientEngagement #PatientProgram
Sam Beavan’s Post
More Relevant Posts
-
Supporting biopharma with access, affordability, and adherence solutions to help patients get the medicine they need to live healthier lives.
Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, Kevin Kettler explores how CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/dhinV2iX #NoBarriers
-
Connecting biopharma with programs that help people get the medicine they need to live healthier lives
Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/eXgypZ2V #NoBarriers
Breaking Down Barriers: Helping Patients Get Therapies Quickly
drugchannels.net
-
Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/e2Wq8yci #NoBarriers
Breaking Down Barriers: Helping Patients Get Therapies Quickly
drugchannels.net
-
Today’s patients have evolved beyond mere medication. They want to actively participate in their #healthcarejourney, access all the information about the drug and its impact on their health conditions, and stay connected to their care providers for instant support. On the other hand, #pharmaceutical companies have also realized the care gap and started expanding Patient support programs (PSPs) to improve patient outcomes and foster loyalty. Such as - ~ Personalized digital solutions alongside the drug that help patients optimize their medication outcomes ~ Personalized in-person support services that cater to patients’ unique health conditions, ensuring convenient and timely access, utilization, and adherence. But how can Pharma further utilize #digitalhealthsolutions, such as patient or companion apps, to close the gap between patient needs and expectations? To find out more, check out our latest blog post: https://lnkd.in/dXzZtmEY #patientexperience #patientcentricity #patientsupport #newpagesolutions
Digital Patient Support Programs For Improved Patient Outcomes
https://www.newpage.io
-
Explore the synergy of HCP engagement and patient centricity in pharma. Discover how this intersection improves outcomes, enhances trust, and drives personalized care. #Pharma #PatientCare #HCPEngagement https://lnkd.in/gAE6bTVg
Exploring the Intersection of HCP Engagement and Patient
https://sixdegreesmed.com
-
For years, patient centricity has primarily focused on healthcare providers. Initially more of a buzzword than a practice, there's now a significant movement to actively involve patients in their care. This shift spans provider medicine, pharmaceutical R&D, and insurance payers, emphasizing personalized medicine, better treatment outcomes, and consumer experience. This blog discusses why patient centricity matters in healthcare and the role of data management in achieving its benefits. #NetApp #ONTAP #DataManagement
Transforming healthcare: The imperative of patient centricity | NetApp Blog
netapp.com
-
For years, patient centricity has primarily focused on healthcare providers. Initially more of a buzzword than a practice, there's now a significant movement to actively involve patients in their care. This shift spans provider medicine, pharmaceutical R&D, and insurance payers, emphasizing personalized medicine, better treatment outcomes, and consumer experience. This blog discusses why patient centricity matters in healthcare and the role of data management in achieving its benefits. #NetApp #ONTAP #DataManagement
Transforming healthcare: The imperative of patient centricity | NetApp Blog
netapp.com
-
An experienced healthcare industry professional connecting Biopharma Manufacturers to patients each day so they can live healthier lives.
Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/ebris-Yv #NoBarriers
Breaking Down Barriers: Helping Patients Get Therapies Quickly
drugchannels.net
-
Healthcare Strategist and Entrepreneur - Passionate about data driven outcomes, thoughtful AI integration into healthcare, and better patient experiences.
By leveraging data, clinical expertise, and digital tools, healthcare payers and pharmaceutical companies can collaborate to improve patient journeys and treatment management in value-based care for chronic diseases. A collaborative, VBC-oriented approach using virtual care models can personalize care delivery, optimize resource allocation, and ultimately improve patient outcomes. #ValueBasedCare #Healthcare #VBC
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
ajmc.com
-
Dynamic and results-driven sales and marketing executive. Proven record of implementing impactful campaigns and strategic initiatives. Deep expertise in fashion, pharma, and supply chain logistics.
Patient groups feel they are making a significant impact with pharma manufacturers to improve the patient experience. The 'bottom-up' marketing strategy - starting with patient input and funneling up to decision-makers, is good business practice compared with conventional 'top-down' management that imposes terms on patient-consumers and contributes to distrust of the pharma industry. https://lnkd.in/grYTrAU3 #transparency #3PLpharma #logistics
Patient groups feel their influence growing among regulators, media and more healthcare stakeholders: survey
fiercepharma.com
